**Dulmar iyo Dib-u-qorid:** Blockchain For Impact (BFI), oo ah sanduuq caafimaad oo la aas aasay xilligii masiibada COVID-19 ee India, ayaa iskaashatay la-taliska CSIR-Central Drug Research Institute (CDRI) si loo kor loogu qaado cilmi-baarista biomedicalka iyo in la dhiirrigeliyo hal-abuurka caafimaadka. Iskaashigan, oo qayb ka ah Barnaamijka Shabakadda Farsamada BFI-BIOME, ayaa diiradda saaraya baahiyaha caafimaad ee deg-degga ah ee malaria, dengue, iyo cudurrada metabolism-ka iyadoo la dhisayo aasaaska horumarada caafimaadka mustaqbalka ee India. BFI, oo ah maalgeliyaha xoojinta ee dhanka blockchain-ka, ayaa xoogga saareysa abuurista iskaashi badan oo waaxyaha ka dhexeeya si wax looga qabto caqabadaha caafimaadka ee India iyo in la taageero kooxaha dulman. Waxa kale oo uu la shaqeeyay Machadka Cilmi-baarista Caafimaadka iyo Farsamada (THSTI) si loo dardargeliyo cilmi-baarista ku saabsan tallaallada, cudurrada faafa, baaritaannada, iyo xaaladaha metabolism-ka, taas oo la jaanqaadaysa aragtida Viksit Bharat (India Horumarsan) ee sanadka 2047 iyo xoojinta hogaaminta biotechnology-ka. Ballanqaadka BFI wuxuu ku fidsan yahay maalgelin muhiim ah, iyadoo in ka badan $150, 000 loo qoondeeyay bilowga caafimaadka ee Jaamacadda Teknoolojiyada Hindiya Kanpur (IITK) iyo $900, 000 saddex sano gudaheed Jaamacadda Teknoolojiyada Hindiya Bombay si kor loogu qaado cilmi-baarista biomedicalka. Iskaashiyo lala sameynayo Jaamacadda Sayniska Hindiya (IISc) ayaa sidoo kale socda si loo taageero mashaariic muhiim ah oo ku saabsan sayniska nolosha. In kasta oo horumar laga sameeyay helitaanka teknoolojiyada sida blockchain iyo sirdoonka macmalka ah (AI) si loo hagaajiyo daryeelka bukaanka iyo amniga xogta, maaraynta xogta bukaanka ayaa weli ah caqabado. Blockchain wuxuu bixin karaa madal ammaan ah oo hufan si loo fududeeyo wadaagga xogta u dhexeeya shirkadaha dawooyinka iyo cilmi-baarayaasha, taas oo dardargelin karta horumarinta daaweynta cusub. Warbixin ay soo saartay PwC ayaa muujineysa in ururada caafimaadka ee caalamiga ah ay ka faa'iidaysanayaan blockchain dalam maaraynta xogta caafimaadka, aqoonsiga, iyo habka silsiladda sahayda.

Si kastaba ha ahaatee, qaybta caafimaadka ee India waxay si tartiib ah u qaadan doontaa teknoolojiyadan markii la sameeyo cilmi-baaris iyo xaqiijin. Siyaasadda cusub ee BioE3 (Biotechnology for Economy, Employment, and Environment) ee India waa talaabo muhiim ah oo lagu horumarinayo qaybta biotechnology-ga iyadoo la dhiirrigelinayo cilmi-baaris hal-abuur leh iyo biomanufacturing. Siyaasaddan ayaa ujeeddadeedu tahay in la hormariyo kaabayaasha sida xarumaha Bio-Artiifishalka AI si loo dardargeliyo cilmi-baarista alaabooyinka ku salaysan noolaha, kuwaas oo muhiim u ah soo saarista dawooyin, tallaallo, iyo agab baaritaan. Siyaasadda BioE3 waxay qeexaysaa istiraatiijiyado lagu xoojinayo biomanufacturing, iyadoo la kaashanayo booska India sida mid ka mid ah lixda sare ee soo saaraha-biyahasieed ee adduunka. Wasiir Jitendra Singh ayaa iftiimiyey muhiimadda teknoolojiyada ee xaqiijinta helitaanka caafimaadka oo loo siman yahay iyo hagaajinta waxtarka nidaamyada gaarsiinta. Warshadaha biomanufacturing ee India ayaa arkay koror ba'an, waxaana la sii saadaalinayaa in uu gaari doono $130 bilyan sanadka 2024, halka qaybta biotechnology-gu ay si suurtagal ah u korodhi doonto ilaa $300 bilyan sanadka 2030. Singh ayaa xusay doorka muhiimka ah ee India ee soo saarista tallaallada caalamiga ah iyo baahida loo qabo hal-abuur joogto ah iyo maalgelin ku saabsan biotechnology si loo adkeeyo hogaaminta.